MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/500/0.01/21.06.24 Share Price

Warrant

DE000MD7LX96

Market Closed - Börse Stuttgart 19:15:28 31/05/2024 BST
0.111 EUR -13.95% Intraday chart for MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/500/0.01/21.06.24
1 month-49.55%
3 months-87.53%
Date Price Change
31/05/24 0.111 -13.95%
30/05/24 0.129 -11.03%
29/05/24 0.145 -39.58%
28/05/24 0.24 +4.35%
27/05/24 0.23 -23.33%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 07:15 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying IDEXX LABORATORIES, INC.
Issuer Morgan Stanley
WKN MD7LX9
ISINDE000MD7LX96
Date issued 30/08/2022
Strike 500 $
Maturity 21/06/2024 (20 Days)
Parity 100 : 1
Emission price 0.13
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.11
Lowest since issue 0.101
Spread 0.023
Spread %15.75%

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
497 USD
Average target price
563.8 USD
Spread / Average Target
+13.45%
Consensus